Stocks
Themes
Market Cap Ranking
Trading Strategies
SEC Filings TLDR
Analysis Reports
Sign in
Loading stock data...
Loading updates and signals...
Back
ALLO
$1.22
-3.17%
Analyze
1M
-2.4%
3M
-18.7%
1Y
-50.0%
Market Cap:
$270.69M
Allogene Therapeutics Inc
Healthcare |
Biotechnology
Allogene Therapeutics, Inc., a clinical-stage immuno-oncology company, develops and markets genetically engineered allogeneic T-cell therapies for the treatment of cancer. The company is headquartered in South San Francisco, California.
Click "Analyze" to generate stock analysis
ALLO Price Trend and Signals
ALLO Option Volumes & Open Interests (aggregated)
ALLO Put Call Ratios and IV (aggregated)
ALLO Financials
Signals
News
SEC Filings
Holders
Research Reports
AI Analysis
2025-10-24
Somewhat Bearish
price_signal
Monthly low detected.
2025-10-14
Somewhat Bearish
macd_signal
Dead cross above zero detected.
2025-10-10
Bearish
price_signal
Large price change detected: -18.54%.
2025-10-09
Somewhat Bullish
price_signal
Monthly high detected.